daraprim

Generic: pyrimethamine

Labeler: vyera pharmaceuticals llc
NDC Directory HUMAN PRESCRIPTION DRUG NDA Inactive Finished

Drug Facts

Product Profile

Brand Name daraprim
Generic Name pyrimethamine
Labeler vyera pharmaceuticals llc
Dosage Form TABLET
Routes
ORAL
Active Ingredients

pyrimethamine 25 mg/1

Manufacturer
Vyera Pharmaceuticals LLC

Identifiers & Regulatory

Product NDC 69413-330
Product ID 69413-330_ca65359c-029c-44f4-ba89-c4058ddd4e30
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category NDA
Application Number NDA008578
Listing Expiration 2026-12-31
Marketing Start 1953-01-23

Pharmacologic Class

Established (EPC)
dihydrofolate reductase inhibitor antimalarial [epc]
Mechanism of Action
dihydrofolate reductase inhibitors [moa]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 69413330
Hyphenated Format 69413-330

Supplemental Identifiers

RxCUI
198182 201912
UPC
0369413330105 0369413330303
UNII
Z3614QOX8W
NUI
N0000175934 N0000000191

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name daraprim (source: ndc)
Generic Name pyrimethamine (source: ndc)
Application Number NDA008578 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 25 mg/1
source: ndc
Packaging
  • 100 TABLET in 1 BOTTLE, PLASTIC (69413-330-10)
  • 30 TABLET in 1 BOTTLE, PLASTIC (69413-330-30)
source: ndc

Packages (2)

Ingredients (1)

pyrimethamine (25 mg/1)

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "ca65359c-029c-44f4-ba89-c4058ddd4e30", "openfda": {"nui": ["N0000175934", "N0000000191"], "upc": ["0369413330105", "0369413330303"], "unii": ["Z3614QOX8W"], "rxcui": ["198182", "201912"], "spl_set_id": ["5368616d-6520-6f6e-2053-686b72656c69"], "pharm_class_epc": ["Dihydrofolate Reductase Inhibitor Antimalarial [EPC]"], "pharm_class_moa": ["Dihydrofolate Reductase Inhibitors [MoA]"], "manufacturer_name": ["Vyera Pharmaceuticals LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "100 TABLET in 1 BOTTLE, PLASTIC (69413-330-10)", "package_ndc": "69413-330-10", "marketing_start_date": "19530123"}, {"sample": false, "description": "30 TABLET in 1 BOTTLE, PLASTIC (69413-330-30)", "package_ndc": "69413-330-30", "marketing_start_date": "19530123"}], "brand_name": "Daraprim", "product_id": "69413-330_ca65359c-029c-44f4-ba89-c4058ddd4e30", "dosage_form": "TABLET", "pharm_class": ["Dihydrofolate Reductase Inhibitor Antimalarial [EPC]", "Dihydrofolate Reductase Inhibitors [MoA]"], "product_ndc": "69413-330", "generic_name": "pyrimethamine", "labeler_name": "Vyera Pharmaceuticals LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Daraprim", "active_ingredients": [{"name": "PYRIMETHAMINE", "strength": "25 mg/1"}], "application_number": "NDA008578", "marketing_category": "NDA", "marketing_start_date": "19530123", "listing_expiration_date": "20261231"}